Glancy Prongay & Murray LLP Reminds Investors of the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
26
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Ternium S.A.

LOS ANGELES, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the January 28, 2019  deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Ternium S.A.(“Ternium” or the “Company”) (NYSE: TX ) securities between  May 1, 2014 and November 27, 2018, inclusive (the “Class Period”). Ternium investors have until  January 28, 2019 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click  here  to participate.

On November 27, 2018, Bloomberg published an article alleging that Ternium’s Chairman Paolo Rocca, was indicted for his role in a graft scheme. Specifically the article alleges that, “the judge charged Rocca after the Argentine billionaire testified that one of his company’s executives paid an undisclosed amount of cash to government officials in monthly installments from 2009 to 2012.” On this news, Ternium’s share price fell $1.42 per share or nearly 5% to close at $28.02 per share on November 27, 2018, thereby injuring investors.

The complaint filed in this class action alleges that, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendant Rocca, Ternium's Chairman, knew that one of his company's executives paid cash to government officials from 2009 to 2012 to expedite compensation payments for the sale of Ternium's Sidor unit; (2) this conduct would lead Rocca to be charged in a graft scheme and subject Ternium, its affiliates, and/or its executives to heightened governmental scrutiny; and (3) as a result, Ternium's public statements were materially false and/or misleading at all relevant times.

Follow us for updates on Twitter: twitter.com/GPM_LLP .

If you purchased shares of Ternium, you may move the Court no later than January 28, 2019  to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy , Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com , or visit our website at www.glancylaw.com . If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts Glancy Prongay and Murray LLP, Los Angeles Lesley Portnoy, 310-201-9150 or 888-773-9224 www.glancylaw.com shareholders@glancylaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lee Enterprises Achieves Major Growth With $16.85 Stock Peak

Updated Category News Views 130

Lee Enterprises Stock Reaches New Heights Lee Enterprises, Incorporated (LEE) has recently made headlines as its stock hit a remarkable 52-week high, trading at $16.85. This surge is indicative of a 61.48% increase over the past year, capturing the attention of both investors and market analysts. Many are watching closely as the company continues to outperform...

Continue Reading
Exciting Upcoming Events by TurfMutt Foundation for Pet Lovers

Updated Category News Views 164

TurfMutt Foundation's Signature Events Announced for 2025 The TurfMutt Foundation is set to bring joy and bring together pet lovers and their furry friends at the upcoming Equip Exposition in 2025. This renowned foundation, known for its commitment to promoting green spaces and animal rescue, is excited to announce its signature events that promise to engage and inspire....

Continue Reading
Significant Advances in PNH Treatment with Novartis' Fabhalta

Updated Category News Views 171

Revolutionizing PNH Treatment with Fabhalta Novartis has showcased exciting developments in the realm of paroxysmal nocturnal hemoglobinuria (PNH) treatment through its innovative oral medication, Fabhalta. The recent Phase IIIB APPULSE-PNH study revealed that adults with PNH, who transitioned to Fabhalta, experienced a notable uptick in hemoglobin (Hb) levels, averaging...

Continue Reading
Current Net Asset Value Overview for Hargreave Hale AIM VCT

Updated Category News Views 146

Understanding the Latest NAV Announcement As of November 28, 2025, Hargreave Hale AIM VCT PLC has reported its unaudited Net Asset Value (NAV). This financial metric is crucial for investors, as it gives a clear indication of the company's performance and value. The NAV per ordinary share of 1p stands at an impressive 35.27 pence, speaking volumes about the company’s...

Continue Reading
Timbercreek Financial Announces Monthly Dividend for Shareholders

Updated Category News Views 243

Timbercreek Financial Announces Exciting Dividend Update Timbercreek Financial (TSX: TF) has made a positive announcement regarding its dividends. Recently, the Company declared a monthly cash dividend of $0.0575 for every common share, showing their commitment to returning value to their shareholders. Dividend Payment Details This dividend is set to be paid on a...

Continue Reading